FDA names controlled substance staff director
Executive Summary
Michael Klein will permanently replace Deborah Leiderman as director of CDER's Controlled Substance Staff. Following Leiderman's exit May 31, Klein was named acting director, and before that, was the team leader and associate director to the staff. Klein has been with CDER for 19 years in a number of offices and previously served as a senior scientist with the DEA